{"Q": 1, "answer": "no", "rationale": "The segment reports stock movement and a potential deal without using intensifiers or comparative risk-adjectives.", "method": "llm_batch", "batch_id": "batch_1_20352", "batch_size": 200, "batch_pos": 130, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "'climbed' is a neutral economic trend verb (Q2 table).", "method": "llm_batch", "batch_id": "batch_2_14832", "batch_size": 200, "batch_pos": 103, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The verb 'climbed' refers to a financial metric, which is excluded from Q3.", "method": "llm_batch", "batch_id": "batch_3_9336", "batch_size": 200, "batch_pos": 72, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_6840", "batch_size": 200, "batch_pos": 70, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports stock market data and potential deal without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17376", "batch_size": 200, "batch_pos": 67, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment contains financial data, not a minimiser used with a scale contrast related to the threat.", "method": "llm_batch", "batch_id": "batch_6_18536", "batch_size": 200, "batch_pos": 43, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_19208", "batch_size": 200, "batch_pos": 38, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment reports stock climbing after a report, not capabilities or preparedness measures.", "method": "llm_batch", "batch_id": "batch_8_14608", "batch_size": 200, "batch_pos": 160, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 9, "answer": "yes", "rationale": "Reports stock price change ('climbed 2.4%') using a standard verb and numerical metric.", "method": "llm_batch", "batch_id": "batch_9_19892", "batch_size": 200, "batch_pos": 17, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
